About Timmune

About company

Timmune is an emerging biotech company incorporated in China. Timmune is focused on T cell redirected immune-oncology. Timmune's core value is in its technology platforms producing in batches first-in-class therapeutics, for the treatment of cancers, to target at intracellular cancer antigens, to redirect T cells, and to improve in-tumor micro-environment. Their products are both fusion protein molecules and cell based. Timmune is led by a team with international experience and expertise in science & discovery, R&D, clinical development, regulatory affairs, business development & partnering, marketing & sales, and financing.